Global trends in diabetes complications: a review of current evidence

Diabetologia

Volumn 62, Issue 1, 2019, Pages 3-16

  Harding, Jessica L ^a   Pavkov, Meda E ^a   Magliano, Dianna J ^b,c   Shaw, Jonathan E ^b   Gregg, Edward W ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Complications (all); Epidemiology; Review; Trends

Indexed keywords

ALL CAUSE MORTALITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; DIABETIC COMPLICATION; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; END STAGE RENAL DISEASE; HUMAN; PRIORITY JOURNAL; REVIEW; DIABETES MELLITUS; INCIDENCE; PREVALENCE; QUALITY OF LIFE;

DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; INCIDENCE; PREVALENCE; QUALITY OF LIFE;

EID: 85053428182     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-018-4711-2     Document Type: Review

References (77)

1. Ogurtsova K, da Rocha Fernandes JD, Huang Y et al (2017) IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 128:40–50
2. International Diabetes Federation (2016) Diabetes and cardiovascular disease. Brussels, Belgium: International Diabetes Federation 2016. Available from www.idf.org/our-activities/care-prevention/cardiovascular-disease/cvd-report. Accessed 24 July 2018
3. Booth GL, Kapral MK, Fung K, Tu JV (2006) Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care 29:32–37
4. Burrows NR, Li Y, Gregg EW, Geiss LS (2018) Declining rates of hospitalization for selected cardiovascular disease conditions among adults aged ≥35 years with diagnosed diabetes, U.S., 1998–2014. Diabetes Care 41:293–302
5. Jung CH, Chung JO, Han K et al (2017) Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006–2013). Cardiovasc Diabetol 16:1
6. Lopez-de-Andres A, Jimenez-Garcia R, Hernandez-Barrera V et al (2014) National trends over one decade in hospitalization for acute myocardial infarction among Spanish adults with type 2 diabetes: cumulative incidence, outcomes and use of percutaneous coronary intervention. PLoS One 9:e85697
7. Lopez-de-Andres A, Jimenez-Trujillo I, Jimenez-Garcia R et al (2015) National trends in incidence and outcomes of abdominal aortic aneurysm among elderly type 2 diabetic and non-diabetic patients in Spain (2003-2012). Cardiovasc Diabetol 14:48
8. Munoz-Rivas N, Mendez-Bailon M, Hernandez-Barrera V et al (2015) Time trends in ischemic stroke among type 2 diabetic and non-diabetic patients: analysis of the Spanish National Hospital Discharge Data (2003-2012). PLoS One 10:e0145535
9. Ringborg A, Lindgren P, Martinell M, Yin DD, Schon S, Stalhammar J (2008) Prevalence and incidence of type 2 diabetes and its complications 1996–2003—estimates from a Swedish population-based study. Diabet Med 25:1178–1186
10. Vamos EP, Millett C, Parsons C, Aylin P, Majeed A, Bottle A (2012) Nationwide study on trends in hospital admissions for major cardiovascular events and procedures among people with and without diabetes in England, 2004–2009. Diabetes Care 35:265–272
11. Yashkin AP, Picone G, Sloan F (2015) Causes of the change in the rates of mortality and severe complications of diabetes mellitus: 1992-2012. Med Care 53:268–275
12. Levi F, Lucchini F, Negri E, La Vecchia C (2002) Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 88:119–124
13. Abi Khalil C, Roussel R, Mohammedi K, Danchin N, Marre M (2012) Cause-specific mortality in diabetes: recent changes in trend mortality. Eur J Prev Cardiol 19:374–381
14. Taylor KS, Heneghan CJ, Farmer AJ et al (2013) All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database. Diabetes Care 36:2366–2371
15. Gregg EW, Cheng YJ, Srinivasan M et al (2018) Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet 391:2430–2440
16. Harding JL, Shaw JE, Peeters A, Davidson S, Magliano DJ (2016) Age-specific trends from 2000–2011 in all-cause and cause-specific mortality in type 1 and type 2 diabetes: a cohort study of more than one million people. Diabetes Care 39:1018–1026
17. Olafsdottir E, Aspelund T, Sigurdsson G et al (2013) Similar decline in mortality rate of older persons with and without type 2 diabetes between 1993 and 2004 the Icelandic population-based Reykjavik and AGES-Reykjavik cohort studies. BMC Public Health 13:36
18. Allemann S, Saner C, Zwahlen M, Christ ER, Diem P, Stettler C (2009) Long-term cardiovascular and non-cardiovascular mortality in women and men with type 1 and type 2 diabetes mellitus: a 30-year follow-up in Switzerland. Swiss Med Wkly 139:576–583
19. Gregg EW, Li Y, Wang J et al (2014) Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med 370:1514–1523
20. Kennon B, Leese GP, Cochrane L et al (2012) Reduced incidence of lower-extremity amputations in people with diabetes in Scotland: a nationwide study. Diabetes Care 35:2588–2590
21. Kurowski JR, Nedkoff L, Schoen DE, Knuiman M, Norman PE, Briffa TG (2015) Temporal trends in initial and recurrent lower-extremity amputations in people with and without diabetes in Western Australia from 2000 to 2010. Diabetes Res Clin Pract 108:280–287
22. Moxey PW, Gogalniceanu P, Hinchliffe RJ et al (2011) Lower-extremity amputations — a review of global variability in incidence. Diabet Med 28:1144–1153
23. Narres M, Kvitkina T, Claessen H et al (2017) Incidence of lower-extremity amputations in the diabetic compared with the non-diabetic population: a systematic review. PLoS One 12:e0182081
24. Carinci F, Massi Benedetti M, Klazinga NS, Uccioli L (2016) Lower extremity amputation rates in people with diabetes as an indicator of health systems performance. A critical appraisal of the data collection 2000–2011 by the Organization for Economic Cooperation and Development (OECD). Acta Diabetol 53:825–832
25. Li Y, Burrows NR, Gregg EW, Albright A, Geiss LS (2012) Declining rates of hospitalization for nontraumatic lower-extremity amputation in the diabetic population aged 40 years or older: U.S., 1988-2008. Diabetes Care 35:273–277
26. Margolis DJ, Hoffstad O, Nafash J et al (2011) Location, location, location: geographic clustering of lower-extremity amputation among Medicare beneficiaries with diabetes. Diabetes Care 34:2363–2367
27. Lopez-de-Andres A, Martinez-Huedo MA, Carrasco-Garrido P, Hernandez-Barrera V, Gil-de-Miguel A, Jimenez-Garcia R (2011) Trends in lower-extremity amputations in people with and without diabetes in Spain, 2001–2008. Diabetes Care 34:1570–1576
28. United States Renal Data System. 2017 USRDS annual data report: epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2017. Available from www.usrds.org/adr.aspx. Accessed 26 July 2018
29. Luk AOY, Hui EMT, Sin MC et al (2017) Declining trends of cardiovascular-renal complications and mortality in type 2 diabetes: The Hong Kong Diabetes Database. Diabetes Care 40:928–935
30. Bullock A, Burrows NR, Narva AS et al (2017) Vital signs: decrease in incidence of diabetes-related end-stage renal disease among American Indians/Alaska Natives — United States, 1996–2013. MMWR Morb Mortal Wkly Rep 66:26–32
31. Group EIS, Stewart JH, McCredie MR, Williams SM (2006) Divergent trends in the incidence of end-stage renal disease due to type 1 and type 2 diabetes in Europe, Canada and Australia during 1998–2002. Diabet Med 23:1364–1369
32. Helve J, Sund R, Arffman M et al (2018) Incidence of end-stage renal disease in patients with type 1 diabetes. Diabetes Care 41:434–439
33. Lin WH, Li CY, Wang WM, Yang DC, Kuo TH, Wang MC (2014) Incidence of end stage renal disease among type 1 diabetes: a nationwide cohort study in Taiwan. Medicine 93:e274
34. Liew G, Wong VW, Ho IV (2017) Mini Review: changes in the incidence of and progression to proliferative and sight-threatening diabetic retinopathy over the last 30 years. Ophthalmic Epidemiol 24:73–80
35. Wong TY, Mwamburi M, Klein R et al (2009) Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care 32:2307–2313
36. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ (2006) The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 55:1463–1469
37. Centers for Disease Control and Prevention. Diabetes Atlas, United States Diabetes Surveillance System 2018. Available from: https://gis.cdc.gov/grasp/diabetes/DiabetesAtlas.html. Accessed 24 July 2018
38. Mathur R, Bhaskaran K, Edwards E et al (2017) Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004–2014. BMJ Open 7:e014444
39. Klein R, Lee KE, Gangnon RE, Klein BE (2010) The 25-year incidence of visual impairment in type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 117:63–70
40. Song SJ, Han K, Choi KS et al (2018) Trends in diabetic retinopathy and related medical practices among type 2 diabetes patients: results from the National Insurance Service Survey 2006–2013. J Diabetes Investig 9:173–178
41. Tracey ML, McHugh SM, Fitzgerald AP, Buckley CM, Canavan RJ, Kearney PM (2016) Trends in blindness due to diabetic retinopathy among adults aged 18–69 years over a decade in Ireland. Diabetes Res Clin Pract 121:1–8
42. Hall HN, Chinn DJ, Sinclair A, Styles CJ (2013) Epidemiology of blindness attributable to diabetes in Scotland: change over 20 years in a defined population. Diabet Med 30:1349–1354
43. Rewers A (2017) Acute metabolic complications in diabetes. In: Diabetes in America, 3rd edn. National Institutes of Health, NIH Pub No. 17-1468; pp 17-1–17-19
44. Klingensmith GJ, Tamborlane WV, Wood J et al (2013) Diabetic ketoacidosis at diabetes onset: still an all too common threat in youth. J Pediatr 162:330–4.e1
45. Booth GL, Hux JE, Fang J, Chan BT (2005) Time trends and geographic disparities in acute complications of diabetes in Ontario, Canada. Diabetes Care 28:1045–1050
46. Lombardo F, Maggini M, Gruden G, Bruno G (2013) Temporal trend in hospitalizations for acute diabetic complications: a nationwide study, Italy, 2001–2010. PLoS One 8:e63675
47. Liu CC, Chen KR, Chen HF, Huang HL, Ko MC, Li CY (2010) Trends in hospitalization for diabetic ketoacidosis in diabetic patients in Taiwan: analysis of national claims data, 1997–2005. J Formos Med Assoc 109:725–734
48. Rao Kondapally Seshasai S, Kaptoge S et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829–841
49. Harding JL, Shaw JE, Peeters A, Guiver T, Davidson S, Magliano DJ (2014) Mortality trends among people with type 1 and type 2 diabetes in Australia: 1997–2010. Diabetes Care 37:2579–2586
50. Thomas RJ, Palumbo PJ, Melton LJ III et al (2003) Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. Arch Intern Med 163:445–451
51. Li HY, Jiang YD, Chang CH, Chung CH, Lin BJ, Chuang LM (2012) Mortality trends in patients with diabetes in Taiwan: a nationwide survey in 2000–2009. J Formos Med Assoc 111:645–650
52. Lind M, Garcia-Rodriguez LA, Booth GL et al (2013) Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study. Diabetologia 56:2601–2608
53. Rosenquist KJ, Fox CS (2017) Mortality trends in type 2 diabetes. In: Diabetes in America, 3rd edn. National Institutes of Health, NIH Pub No. 17-1468; pp 36-1–36-14
54. Secrest AM, Washington RE, Orchard TJ 2017 Mortality in type 1 diabetes. In: Diabetes in America, 3rd edn. National Institutes of Health, NIH Pub No. 17-1468; pp 35-1–35-16
55. Centers for Disease Control and Prevention (2012) Diabetes death rates among youths aged ≤19 years — United States, 1968–2009. MMWR Morb Mortal Wkly Rep 61:869–872
56. Asao K, Sarti C, Forsen T et al (2003) Long-term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland. Diabetes Care 26:2037–2042
57. Gagnum V, Stene LC, Sandvik L et al (2015) All-cause mortality in a nationwide cohort of childhood-onset diabetes in Norway 1973–2013. Diabetologia 58:1779–1786
58. Forssas E, Arffman M, Koskinen S, Reunanen A, Keskimaki I (2010) Socioeconomic differences in mortality among diabetic people in Finland. Scand J Public Health 38:691–698
59. Zghebi SS, Steinke DT, Carr MJ, Rutter MK, Emsley RA, Ashcroft DM (2017) Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014. Diabetes Obes Metab 19:1537–1545
60. Green A, Sortso C, Jensen PB, Emneus M (2015) Incidence, morbidity, mortality, and prevalence of diabetes in Denmark, 2000–2011: results from the Diabetes Impact Study 2013. Clin Epidemiol 7:421–430
61. Karpati T, Cohen-Stavi CJ, Leibowitz M, Hoshen M, Feldman BS, Balicer RD (2014) Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel. Popul Health Metrics 12:32
62. Read SH, Kerssens JJ, McAllister DA et al (2016) Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013. Diabetologia 59:2106–2113
63. Egede LE, Hull BJ, Williams JS (2017) Infections associated with diabetes. In: Diabetes in America, 3rd edn. National Institutes of Health, NIH Pub No. 17-1468; pp 30-1-30-25
64. de Miguel-Yanes JM, Mendez-Bailon M, Jimenez-Garcia R, Hernandez-Barrera V, Perez-Farinos N, Lopez-de-Andres A (2015) Trends in sepsis incidence and outcomes among people with or without type 2 diabetes mellitus in Spain (2008–2012). Diabetes Res Clin Pract 110:266–275
65. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K (2006) The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med 23:1165–1173
66. Fisher L, Skaff MM, Mullan JT, Arean P, Glasgow R, Masharani U (2008) A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes. Diabet Med 25:1096–1101
67. Ward A, Troop N, Cachia M, Watkins P, Treasure J (1995) Doubly disabled: diabetes in combination with an eating disorder. Postgrad Med J 71:546–550
68. Vancampfort D, Correll CU, Galling B et al (2016) Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry 15:166–174
69. Li J, Shao YH, Gong YP, Lu YH, Liu Y, Li CL (2014) Diabetes mellitus and dementia - a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 18:1778–1789
70. Gregg EW, Menke A (2017) Diabetes and disability. In: Diabetes in America, 3rd edn. National Institutes of Health, NIH Pub No. 17-1468; pp 34-1–34-15
71. Lopez-de-Andres A, Jimenez-Trujillo MI, Hernandez-Barrera V et al (2015) Trends in the prevalence of depression in hospitalized patients with type 2 diabetes in Spain: analysis of hospital discharge data from 2001 to 2011. PLoS One 10:e0117346
72. Manderbacka K, Sund R, Koski S, Keskimaki I, Elovainio M (2011) Diabetes and depression? Secular trends in the use of antidepressants among persons with diabetes in Finland in 1997–2007. Pharmacoepidemiol Drug Saf 20:338–343
73. Ford ES (2011) Trends in the control of risk factors for cardiovascular disease among adults with diagnosed diabetes: findings from the National Health and Nutrition Examination Survey 1999–2008*. J Diabetes 3:337–347
74. Imperatore G, Cadwell BL, Geiss L et al (2004) Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971–2000. Am J Epidemiol 160:531–539
75. GBD 2016 Risk Factors Collaborators (2017) Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1345–1422
76. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7–22
77. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW (2013) Achievement of goals in U.S. diabetes care, 1999–2010. N Engl J Med 368:1613–1624